Skip to main content
Signal8

Holtzman Steven H

SEC insider (Form 3/4/5 filer). CIK 0001300247. Director at Camp4 Therapeutics Corp (CAMP). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in CAMBRIDGE, MA.

Companies Holtzman Steven H has filed insider reports for

  • Camp4 Therapeutics Corp (CAMP): Director
Holtzman Steven H profile photo

Holtzman Steven H

CIK: 0001300247

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Camp4 Therapeutics Corp logo
CAMP

Camp4 Therapeutics Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Jun 10, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    28K shares-
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Jun 25, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    9K shares-
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Oct 15, 2024
    Conversion
    Direct
    8.9K shares-

1-3 of 3